BioSpace News Archive

Cortexyme, Inc. today announced that its board of directors has appointed Christopher Lowe, the company’s chief operating officer and chief financial officer, as interim chief executive.

Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the execution of an agreement with MultiPlan, for participation in its PHCS and MultiPlan Networks.

AmerisourceBergen , a global healthcare company, released its 2021 Global Sustainability Report and Environmental, Social and Governance (ESG) Reporting Index, detailing the impact of its robust sustainability and community efforts.

Neuvivo today announced the publication of a paper on its lead candidate drug NP001 for the treatment of ALS in the peer-reviewed journal Muscle & Nerve.

The fourth calendar quarter of 2021 financial results demonstrate Utah Medical Products, Inc.’s continuing performance improvement despite many challenges related to the corona virus pandemic including on-again/off-again restrictions on so-called nonessential medical procedures, supply chain disruption, high inflation on raw materials, freight and labor costs as well as a continued shortage of labor and higher employee turnover.

SOPHiA GENETICS have announced, in conjunction with Assises de Génétique, an extension of their partnership with Institut Paoli Calmettes, one of the 18 French Cancer Comprehensive Centers, to further support the implementation, automatization, and accreditation of solid tumor tests, to include lung, breast, ovarian and onco-hematological cancers.

EmitBio, Inc., a biotechnology company at the intersection of light and life science, today announced successful results from a series of in vitro experiments targeting Omicron and other SARS-CoV-2 variants.

Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, achieved several clinical, reimbursement and regulatory milestones in the past 12 months that are moving its LimiFlex™ Dynamic Sagittal Tether™ (DST) closer to market in the US.

AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of KardiaMobile Card, the slimmest, most convenient personal ECG device ever created.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today announced that it has engaged Professor Stephen Neidle as a scientific advisor.